AIDX
20/20 Biolabs Inc
AIDX
Closed
$0.55
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
20/20 Biolabs, Inc. engages in development and commercialization of proteomics product line. The company is headquartered in Rockville, Maryland and currently employs 4 full-time employees. The firm offers OneTest, a simple blood test for multiple cancers, harnesses the power of Artificial Intelligence (AI) to help identify the disease at an earlier, more treatable stage. Onetest helps detect Lung, Liver, Pancreatic, Prostate, Kidney, Ovarian and many other cancers with a single blood test.
Key stats
Open
$0.50
Volume
230.86K
Market cap
$7.08M
Prev. close
$0.55
Impl / hst vl
-
Open interest
$0.00
$0.50
Day’s Range
$0.64
$0.40
52W Range
$20.66
Valuation
50
Valuation score
Fairly Valued
P/E
-
P/S
-
P/B
-
Current ratio
1.82
Debt / Equity
-
ROE
-
Gross margin
17.80%
Income growth
62.15%
FCF growth
152.94
Analysts estimates
Consensus rating
Buy
The average rating from top 4 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$5.10
The top 3 analysts forecasts that 12-month price may increase by 827.27%, with a low of $5.05 and a high of $5.25
$5.05
Low
$5.10
Avg
$5.25
High
Current price
Earnings
Q1 ‘26 revenue
$353.40K
Q1 ‘26 net income
-$2.12M
Revenue
Net income
Discover more Shariah-compliant stocks
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply